Use of Open Access Platforms for Clinical Trial Data.
Publication
, Journal Article
Navar, AM; Pencina, MJ; Rymer, JA; Louzao, DM; Peterson, ED
Published in: Jama
March 22, 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Jama
DOI
EISSN
1538-3598
Publication Date
March 22, 2016
Volume
315
Issue
12
Start / End Page
1283 / 1284
Location
United States
Related Subject Headings
- Information Dissemination
- Humans
- General & Internal Medicine
- Drug Industry
- Databases, Factual
- Clinical Trials as Topic
- Access to Information
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Navar, A. M., Pencina, M. J., Rymer, J. A., Louzao, D. M., & Peterson, E. D. (2016). Use of Open Access Platforms for Clinical Trial Data. Jama, 315(12), 1283–1284. https://doi.org/10.1001/jama.2016.2374
Navar, Ann Marie, Michael J. Pencina, Jennifer A. Rymer, Darcy M. Louzao, and Eric D. Peterson. “Use of Open Access Platforms for Clinical Trial Data.” Jama 315, no. 12 (March 22, 2016): 1283–84. https://doi.org/10.1001/jama.2016.2374.
Navar AM, Pencina MJ, Rymer JA, Louzao DM, Peterson ED. Use of Open Access Platforms for Clinical Trial Data. Jama. 2016 Mar 22;315(12):1283–4.
Navar, Ann Marie, et al. “Use of Open Access Platforms for Clinical Trial Data.” Jama, vol. 315, no. 12, Mar. 2016, pp. 1283–84. Pubmed, doi:10.1001/jama.2016.2374.
Navar AM, Pencina MJ, Rymer JA, Louzao DM, Peterson ED. Use of Open Access Platforms for Clinical Trial Data. Jama. 2016 Mar 22;315(12):1283–1284.
Published In
Jama
DOI
EISSN
1538-3598
Publication Date
March 22, 2016
Volume
315
Issue
12
Start / End Page
1283 / 1284
Location
United States
Related Subject Headings
- Information Dissemination
- Humans
- General & Internal Medicine
- Drug Industry
- Databases, Factual
- Clinical Trials as Topic
- Access to Information
- 11 Medical and Health Sciences